Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Cancer Medicine
|
April 21, 2023
Metastatic sites and lesion numbers cooperated to predict efficacy of PD-1 inhibitor-based combination therapy for patients with metastatic colorectal cancer
Weiqin Jiang, Yinjun He, Wenguang He, et al.
Frontiers in Immunology
|
February 26, 2021
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
Weiqin Jiang, Yinjun He, Wenguang He, et al.
Journal of Visualized Experiments : Jove
|
November 17, 2025
ML385 Attenuates Malignant Progression of Silica-induced Lung Adenocarcinoma Cells through the ROS/NRF2-autophagy Axis Pathway
Yanhong Cao, Wubi Zhou, Junwen Cai, et al.
Radiology. Artificial Intelligence
|
February 14, 2024
Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal Cancer at MRI
Wei Xia, Dandan Li, Wenguang He, et al.
Quantitative Imaging in Medicine and Surgery
|
July 18, 2024
Multiparametric magnetic resonance imaging (MRI)-based radiomics model explained by the Shapley Additive exPlanations (SHAP) method for predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter retrospective study
Yiqi Wang, Luyuan Zhang, Yanting Jiang, et al.
Journal of Translational Medicine
|
January 13, 2023
Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
Yinjun He, Xiang Zhang, Ming Zhu, et al.
Frontiers in Immunology
|
January 26, 2023
Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy
Hanju Hua, Wenguang He, Nan Chen, et al.
British Journal of Pharmacology
|
February 16, 2020
JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt
Xiunan Wang, Yan Yang, Dandan Ren, et al.
Therapeutic Advances in Medical Oncology
|
January 31, 2024
Reclassification of <i>RAS/BRAF</i> allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer
Xiang Zhang, Haizhong Ma, Yinjun He, et al.
Molecular Therapy. Nucleic Acids
|
September 13, 2021
Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer
Libin Song, Simin Qi, Wei Hu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Cancer Medicine
|
April 21, 2023
Metastatic sites and lesion numbers cooperated to predict efficacy of PD-1 inhibitor-based combination therapy for patients with metastatic colorectal cancer
Weiqin Jiang, Yinjun He, Wenguang He, et al.
Frontiers in Immunology
|
February 26, 2021
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
Weiqin Jiang, Yinjun He, Wenguang He, et al.
Journal of Visualized Experiments : Jove
|
November 17, 2025
ML385 Attenuates Malignant Progression of Silica-induced Lung Adenocarcinoma Cells through the ROS/NRF2-autophagy Axis Pathway
Yanhong Cao, Wubi Zhou, Junwen Cai, et al.
Radiology. Artificial Intelligence
|
February 14, 2024
Multicenter Evaluation of a Weakly Supervised Deep Learning Model for Lymph Node Diagnosis in Rectal Cancer at MRI
Wei Xia, Dandan Li, Wenguang He, et al.
Quantitative Imaging in Medicine and Surgery
|
July 18, 2024
Multiparametric magnetic resonance imaging (MRI)-based radiomics model explained by the Shapley Additive exPlanations (SHAP) method for predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicenter retrospective study
Yiqi Wang, Luyuan Zhang, Yanting Jiang, et al.
Journal of Translational Medicine
|
January 13, 2023
Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
Yinjun He, Xiang Zhang, Ming Zhu, et al.
Frontiers in Immunology
|
January 26, 2023
Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy
Hanju Hua, Wenguang He, Nan Chen, et al.
British Journal of Pharmacology
|
February 16, 2020
JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt
Xiunan Wang, Yan Yang, Dandan Ren, et al.
Therapeutic Advances in Medical Oncology
|
January 31, 2024
Reclassification of <i>RAS/BRAF</i> allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer
Xiang Zhang, Haizhong Ma, Yinjun He, et al.
Molecular Therapy. Nucleic Acids
|
September 13, 2021
Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer
Libin Song, Simin Qi, Wei Hu, et al.
Page
of 6